AUS
NZ
UK
CA
USA
IND
.jpg)
.jpg)
_05_16_2023_17_11_27_393572.jpg)
Highlights
- Healthcare sector has shown tremendous growth amid the Covid-19 pandemic.
- The healthcare sector includes a range of companies providing drugs, medical devices, and healthcare providers.
- Investing in the stocks of these healthcare companies can be a smart choice for investors in the current economic climate.
Healthcare is one of the largest sectors globally as healthcare services are utmost important for everyone. Amid the Covid-19 pandemic, the sector has outgrown the overall growth of the global economy due to rising demand for healthcare products and services. The healthcare sector includes a range of companies providing drugs, medical devices, and healthcare providers.
Investing in the stocks of these healthcare companies can be a smart choice for investors in the current economic climate due to their increasing profitability and bright future prospects.
Here are 5 FTSE healthcare stocks, which have given high returns to investors this year and are worth adding to your portfolio for 2022.
RELATED READ: Omicron scare: WHO issues warning, healthcare stocks to invest in
© 2021 Kalkine Media®
e-Therapeutics plc (LON: ETX)
e-Therapeutics plc is an Oxford-based drug discovery and development firm. The market cap of the AIM-listed company stood at £249.04 million as of 13 December 2021. It has given a return of 186.74% to its shareholders in the last one year and its year-to-date return stands at 174.29% as of 13 December 2021.
e-Therapeutics plc’s shares were trading at GBX 48.00 at 10:30 AM (GMT) on 13 December 2021.
ANGLE plc (LON: AGL)
ANGLE plc is a leading UK-based liquid biopsy company which specialises in medical diagnostics. The market cap of the AIM-listed company stood at £306.85 million as of 13 December 2021. It has given a return of 220.63% to its shareholders in the last one year and its year-to-date return stands at 167.58% as of 13 December 2021.
ANGLE plc’s shares were trading at GBX 129.00 at 10:40 AM (GMT) on 13 December 2021.
Belluscura PLC (LON: BELL)
Belluscura PLC is a UK-based medical device firm which focusing on oxygen enrichment technology. The market cap of the AIM-listed company stood at £141.16 million as of 13 December 2021. It has given a return of 134.50% to its shareholders in the last one year and its year-to-date return stands at 134.00% as of 13 December 2021.
Belluscura plc’s shares were trading at GBX 124.00 at 10:45 AM (GMT) on 13 December 2021.
RELATED READ: Sunak increases healthcare spending by £44 bn: 2 stocks to buy
Netscientific PLC (LON: NSCI)
Netscientific PLC is a UK-based holding company which is engaged in the commercialisation of healthcare intellectual property. The market cap of the AIM-listed company stood at £22.02 million as of 13 December 2021. It has given a return of 134.04% to its shareholders in the last one year and its year-to-date return stands at 143.90% as of 13 December 2021.
Netscientific plc’s shares were trading at GBX 106.00 at 10:48 AM (GMT) on 13 December 2021.
Sareum Holdings Plc (LON: SAR)
Sareum Holdings Plc is a UK-based pharmaceutical company which is engaged in discovering drugs for diseases like cancer. The market cap of the AIM-listed company stood at £176.97 million as of 13 December 2021. It has given a return of 293.28% to its shareholders in the last one year and its year-to-date return stands at 111.65% as of 13 December 2021.
Sareum Holdings plc’s shares were trading at GBX 5.15 at 10:54 AM (GMT) on 13 December 2021.
